Come up with a name for your new list and we'll add to it:
ProTA Therapeutics raised a round of funding on May 29, 2017. Investors include
National Innovation and Science Agenda.
ProTA Therapeutics (Probiotic Therapies for Allergy) is an immunotherapy technology developer aiming to commercialize new peanut allergy treatments for children. The allergy treatment that combines a …